Lacosamide Injection
Product Images NDC 72603-263

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 72603-263). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Aspiro (Aspiro)

Aspiro (Aspiro)
FDA Label Image

Lacosamide-inj-fig-1 (Lacosamide Inj Fig 1)

Lacosamide-inj-fig-1 (Lacosamide Inj Fig 1)
This information shows the percentage of seizure reduction with different doses of Lacosamide compared to a placebo in a clinical trial. The table displays the results for 200mg, 400mg, and 600mg doses of Lacosamide, highlighting the statistical significance in seizure reduction compared to the placebo.*
FDA Label Image

Lacosamide-inj-fig-2 (Lacosamide Inj Fig 2)

Lacosamide-inj-fig-2 (Lacosamide Inj Fig 2)
This text provides information on responder rates for different dosages of lacosamide as compared to placebo. The responder rates are categorized into improvement, worsening, and percentages based on different dosage levels. The data includes the number of patients in each group and the percentage of patients within each category.*
FDA Label Image

Lacosamide-inj-structure (Lacosamide Inj Structure)

Lacosamide-inj-structure (Lacosamide Inj Structure)
FDA Label Image

Lacosamideviallabel10mgml (Lacosamide Vial Label 10 mg mL)

Lacosamideviallabel10mgml (Lacosamide Vial Label 10 mg mL)
FDA Label Image

Lacosamidevialcarton10mgml. (Lacosamidevialcarton10mgml)

Lacosamidevialcarton10mgml. (Lacosamidevialcarton10mgml)
The text contains information about a pharmaceutical product: Lacosamide Injection, available in a strength of 200 mg/20 mL. The product is intended for intravenous use and batch details along with a 2D data matrix will be coded or printed on it. The text also includes instructions and dosage information for pharmacists. Finally, it mentions that the product will have an unvarnished area.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.